Predica’s patent granted in the EU

Written By Predica Diagnostics

Predica’s patent on targeted RNA sequencing has been granted in the European Union.

With Predica’s technology, we will support elimination of cervical cancer and other Women’s Health related diseases.

Please contact us if you are interested to learn more about our developments

Predica Diagnostics
Previous

PREDICA participating in the INTERREG project SMARTGUT
Next

A successful combination: The Ellele Sampling Device from Ellele Health and the HPV profiler from Predica Diagnostics